全球免疫組織化學市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

全球免疫組織化學市場需求預計將從 2022 年的 51.1 億美元達到 2030 年近 125.7 億美元的市場規模，2023-2030 年研究期間複合CAGR為 10.52%。

免疫組織化學 (IHC) 協助診斷和研究實驗室識別酵素、腫瘤抑制基因、抗原和腫瘤細胞增生。它包括不同類型細胞中目標蛋白的存在和定位、生物週期甚至複雜組織內的亞細胞定位的可視化。 IHC 在臨床診斷中越來越受歡迎，因為它用於診斷癌症、傳染病、心血管疾病和自體免疫疾病等慢性疾病。 IHC 用於研究應用，在細胞、分子或組織層面分析感興趣的分子，以研究它們在健康和患病細胞和組織中的作用。

市場動態：

慢性病的高盛行率預計將增加對免疫組織化學解決方案的需求，從而促進市場成長。此外，人們對更好生活品質的日益關注和醫療保健支出的增加預計將提振市場。此外，IHC技術也用於治療心臟病、藥物開發、傳染病、內分泌、藥物濫用檢測等疾病，為市場帶來了推動。此外，該技術在癌症診斷方面發揮了重要作用。因此，癌症盛行率的上升預計將增加對免疫組織化學的需求，從而促進市場成長。然而，IHC 技術缺乏特異性及其高昂的設置成本預計將限制免疫組織化學市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球免疫組織化學市場的每個細分市場進行了包容性評估。免疫組織化學產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲免疫組織化學市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。免疫組織化學市場的主要參與者包括Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd.、Merck KGaA、Danaher Corporation、PerkinElmer, Inc.、Bio-Rad Laboratories, Inc.、Cell Signaling Technology, Inc.、 Bio SB、Abcam plc.、安捷倫科技公司。本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布，以及其他進展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：免疫組織化學 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 市場吸引力分析：依應用分類
  • 按最終用途分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球免疫組織化學市場分析：按產品

• 按產品概述
• 歷史和預測數據
• 按產品分析
• 抗體（一抗、二抗）
• 設備（玻片染色系統、組織微陣列、組織處理系統、玻片掃描器等）
• 試劑（組織學染色劑、封閉血清及試劑、顯色底物、固定試劑、穩定劑、有機溶劑、蛋白水解酶、稀釋劑、試劑盒）

第 7 章：全球免疫組織化學市場分析：依應用分類

• 概述：按應用
• 歷史和預測數據
• 分析：按應用
• 診斷（癌症、傳染病、心血管疾病、自體免疫疾病、糖尿病、腎臟病）
• 藥物檢測

第 8 章：全球免疫組織化學市場銷售分析：依最終用途

• 按最終用途分類的概述
• 歷史和預測數據
• 按最終用途分析
• 醫院和診斷實驗室
• 研究機構
• 其他

第 9 章：全球免疫組織化學市場銷售分析：按地理位置

• 區域展望銷售分析
• 簡介 銷售分析
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 10 章：免疫組織化學公司的競爭格局

• 免疫組化市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 11 章：公司簡介

• 十大公司股票分析
• 市場集中度
• Thermo Fisher Scientific Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• F. Hoffmann-La Roche Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Merck KGaA
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Danaher Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• PerkinElmer Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bio-Rad Laboratories Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Cell Signaling Technology Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bio SB
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Abcam plc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Agilent Technologies Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Immunohistochemistry Market is presumed to reach the market size of nearly USD 12.57 BN by 2030 from USD 5.11 BN in 2022 with a CAGR of 10.52% under the study period 2023 - 2030.

Immunohistochemistry (IHC) assists in diagnostic and research laboratories to identify enzymes, tumor suppressor genes, antigens, and tumor cell proliferation. It includes the visualization of the presence and localization of the target protein in different types of cells, biological cycles and even subcellular localization within the complex tissues. IHC has gained popularity in clinical diagnostics as it is used to diagnose chronic diseases such as cancer, infectious diseases, cardiovascular diseases, and autoimmune disorders. IHC is used in research applications where molecules of interest are analyzed on the cellular, molecular, or tissue level to study their roles in both healthy and diseased cells and tissues.

MARKET DYNAMICS:

The high prevalence of chronic diseases is expected to increase demand for immunohistochemistry solutions contributing to market growth. Moreover, the increased concern for experiencing a better quality of life and increased healthcare spending are expected to boost the market. Besides that, the IHC technique is used to treat diseases such as heart disease, drug development, infectious disease, endocrinology, and drug abuse testing, giving the market a boost. Furthermore, the technique has played an important role in shaping cancer diagnostics. As a result, the rising prevalence of cancer is expected to increase the demand for immunohistochemistry, thus contributing to market growth. However, the lack of specificity associated with IHC techniques and its high setup cost is anticipated to restrict the growth of the market for immunohistochemistry.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of immunohistochemistry. The growth and trends of immunohistochemistry industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the immunohistochemistry market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Antibodies (Primary Antibodies, Secondary Antibodies)
• Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others)
• Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits)

By Application

• Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases)
• Drug Testing

By End-Use

• Hospitals & Diagnostic Laboratories
• Research Institutes
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Immunohistochemistry market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Immunohistochemistry market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Abcam plc., Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . IMMUNOHISTOCHEMISTRY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Antibodies (Primary Antibodies, Secondary Antibodies) Historic and Forecast Sales by Regions
• 6.5 Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Historic and Forecast Sales by Regions
• 6.6 Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Historic and Forecast Sales by Regions

7 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Historic and Forecast Sales by Regions
• 7.5 Drug Testing Historic and Forecast Sales by Regions

8 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET SALES ANALYSIS BY END-USE

• 8.1 Overview by End-use
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-use
• 8.4 Hospitals & Diagnostic Laboratories Historic and Forecast Sales by Regions
• 8.5 Research Institutes Historic and Forecast Sales by Regions
• 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE IMMUNOHISTOCHEMISTRY COMPANIES

• 10.1. Immunohistochemistry Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF IMMUNOHISTOCHEMISTRY INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Thermo Fisher Scientific Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. F. Hoffmann-La Roche Ltd.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Merck KGaA
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Danaher Corporation
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. PerkinElmer Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Bio-Rad Laboratories Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Cell Signaling Technology Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Bio SB
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Abcam plc.
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. Agilent Technologies Inc.
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Antibodies (Primary Antibodies, Secondary Antibodies) Market Sales by Geography (USD MN)
• Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Market Sales by Geography (USD MN)
• Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Market Sales by Geography (USD MN)
• Drug Testing Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
• Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Immunohistochemistry Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Immunohistochemistry Report
• Market Research Process
• Market Research Methodology
• Global Immunohistochemistry Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Antibodies (Primary Antibodies, Secondary Antibodies) Market Sales by Geography (USD MN)
• Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Market Sales by Geography (USD MN)
• Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Market Sales by Geography (USD MN)
• Drug Testing Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
• Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.